Results 131 to 140 of about 45,911 (237)

Assessment of environmental radioactivity in the City of Melilla. [PDF]

Sci Rep
Rubiano JG, Cámara F, Miquel-Armengol N, Briones C, León-Navarro C, Añino M, Alonso H, Tejera A, Martel P.   +8 more
europepmc   +1 more source

Assessment of radiological hazards arising from natural radioactivity in Bayburt stones used in buildings and possible effects on public health. [PDF]

Front Public Health
Dizman S, Umar M, Hatipoglu YS.
europepmc   +1 more source

Radioisotope [PDF]

, 2020
openaire   +1 more source

An adapted methodology to characterize the neutron emission of californium neutron sources. [PDF]

Radiat Prot Dosimetry
Stabilini A, Geser FA, Kasprzak M, Mayer S.   +3 more
europepmc   +1 more source

Diverse DTPA-chelated lanthanides with relevance for nuclear medicine bound to an engineered lipocalin reveal conserved ligand geometry. [PDF]

Acta Crystallogr F Struct Biol Commun
Mirwald A, Eichinger A, Skerra A.
europepmc   +1 more source

Synthesis and <i>in vitro</i> evaluation of dual-modality radio-fluorescent probes ([¹³¹I]I-BNF03 and [¹³¹I]I-WS03) for cancer cell imaging. [PDF]

RSC Adv
Widyasari EM, Flourentin AM, Ramadhani D, Wongso H, Santoso M, Permana B, Puspitasari T, Tjahjono DH.   +7 more
europepmc   +1 more source

The Global Theranostics Access Gap: Real-World Disparities in PSMA PET/CT and ¹⁷⁷Lu-PSMA Therapy Between Centers in Brazil and Europe. [PDF]

J Nucl Med
Cerci JJ, Fanti S, Herrmann K, Rodrigues DF, Leite PHF, Masukawa M, da Silva MM, Fendler WP, Goncalves E Silva A, Sanfelice EN, Ayelet W, Ghetti F, Bascioni A, Estrado Lobato EE, Paez D.   +14 more
europepmc   +1 more source

Editorial: Production of novel medical radionuclides and innovative radiopharmaceuticals

Frontiers in Chemistry
Susanta Lahiri, Susanta Lahiri
doaj   +1 more source

<i>CopperNostics</i>-Here We Are Now, Entertain Us! [PDF]

Pharmaceuticals (Basel)
Brühlmann SA, Walther M, Kopka K, Kreller M, Kiss OC.   +4 more
europepmc   +1 more source

Optimization of next-generation CXCR4 ligands for radiotheranostic applications. [PDF]

Front Pharmacol
Astiazarán-Rascón IR, Lau J, Bénard F.   +2 more
europepmc   +1 more source